Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (531-540 of 610) with videos related to

Pageof 61
Sort By:
International Journal of Molecular Sciences|July 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal CancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
Journal for Immunotherapy of Cancer|June 13, 2018
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapyAmber J Giles, Marsha-Kay N D Hutchinson, Heather M Sonnemann, et al.
Blood|October 16, 2004
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemiasStefan Faderl, Varsha Gandhi, Susan O'Brien, et al.
Journal of Clinical Pathology|May 25, 2011
A prospective randomised study of a rotary powered device (OnControl) for bone marrow aspiration and biopsyRonan T Swords, Javier Anguita, Russell A Higgins, et al.
Blood|August 15, 2002
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemiaHagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignanciesGloria N Mattiuzzi, Gladys Alvarado, Francis J Giles, et al.
Leukemia Research|June 11, 2013
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignanciesCarlos Graux, Anne Sonet, Johan Maertens, et al.
Leukemia|May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapyA-M Tsimberidou, H M Kantarjian, E Estey, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 TrialBenedito A Carneiro, Bhavana Konda, Rubens B Costa, et al.
Pageof 61

Showing results (531-540 of 610) with videos related to

Sort By:
Pageof 61
International Journal of Molecular Sciences|July 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal CancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
Journal for Immunotherapy of Cancer|June 13, 2018
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapyAmber J Giles, Marsha-Kay N D Hutchinson, Heather M Sonnemann, et al.
Blood|October 16, 2004
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemiasStefan Faderl, Varsha Gandhi, Susan O'Brien, et al.
Journal of Clinical Pathology|May 25, 2011
A prospective randomised study of a rotary powered device (OnControl) for bone marrow aspiration and biopsyRonan T Swords, Javier Anguita, Russell A Higgins, et al.
Blood|August 15, 2002
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemiaHagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignanciesGloria N Mattiuzzi, Gladys Alvarado, Francis J Giles, et al.
Leukemia Research|June 11, 2013
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignanciesCarlos Graux, Anne Sonet, Johan Maertens, et al.
Leukemia|May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapyA-M Tsimberidou, H M Kantarjian, E Estey, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 TrialBenedito A Carneiro, Bhavana Konda, Rubens B Costa, et al.
Pageof 61